EGFR and lung adenocarcinoma: Pathologically, the aberrant expression of EGFR was found in more than half of non-small-cell lung cancer (NSCLC) patients 28 and mutations in the kinase domain of the EGFR gene are detected in approximately 40% of East Asian lung adenocarcinoma patients 29.